Ethasyl Injection contains Ethamsylate 250mg, a hemostatic agent used to reduce bleeding by improving platelet adhesiveness and restoring capillary resistance. It is commonly prescribed to prevent and control hemorrhages in various clinical conditions such as menorrhagia, postoperative bleeding, and capillary bleeding associated with vascular disorders. Ethamsylate works by promoting the formation of platelet plugs at the site of vascular injury, thereby enhancing primary hemostasis without affecting blood coagulation parameters significantly. This injection is particularly useful in surgical settings, trauma cases, and certain gynecological conditions where excessive bleeding poses a risk. Administered intramuscularly or intravenously, Ethasyl Injection provides rapid onset of action, making it effective for acute bleeding episodes. It is generally well tolerated, with minimal side effects, though some patients may experience mild reactions such as nausea, headache, or skin rash. Ethasylate should be used cautiously in patients with known hypersensitivity to the drug or in those with severe renal or hepatic impairment. Overall, Ethasyl Injection is a valuable therapeutic option for managing bleeding disorders, ensuring hemostasis, and supporting patient recovery in various medical scenarios.